Overall rank by patents
#41,046
of 49,997 tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 6 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture).
The verdict
According to USPTO PatentsView, Isobionics ranks #41,046 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 6 technology areas.
USPTO PatentsView assignee plate
Corpus R41046 · Foreign Corporation #41,046 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: ISA Pharmaceuticals B.V. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Isobionics B V · this assignee
30 score
3D Lighting… · lowest
7 score
What this shows Isobionics's Innovation Score is 30.4/100 (34th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Isobionics B.V. is a focused PatentsView assignee: 6 CPC subclasses with 66.7% of grants classified under C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2016. By volume, Isobionics sits between ISA Pharmaceuticals B.V. and Isringhausen GmbH & Co. KG.
Isobionics B.V. shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ISA Pharmaceuticals B.V.
6 patents
Isarna Therapeutics GMBH
6 patents
Iscilab Corporation
6 patents
Ismeca Semiconductor Holding SA
6 patents
Isol8 (HOLDINGS) Limited
6 patents
Isopure, Corp.
6 patents
Isotek Microwave Limited
6 patents
Isringhausen GmbH & Co. KG
6 patents
Isobionics B.V.
6 patents
What this shows Isobionics holds 6 patents at rank #40,932, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #40,932 in granted patent volume.
Other assignees with the most granted patents in Isobionics's primary technology class.
Isobionics's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
30 34th percentile higher than 34% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 16.7% |
| 2021 | 2 | 33.3% |
| 2022 | 1 | 16.7% |
| 2023 | 1 | 16.7% |
| 2025partial year | 1 | 16.7% |
Top 6 of 6 technology areas
Overall rank by patents
#41,046
of 49,997 tracked assignees
30.4 out of 100
What to do with this data
Isobionics B.V.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.